Коррекция сдвига пула желчных кислот у вьюнов с экспериментальными гепатопатиями сульфолитохолевой кислотой
Biochemical parameters of loach blood serum on the 35th day of pharmacocorrection
M ± SD; * — p < 0.05 compared with the control; # — p < 0.05 compared with the corresponding untreated group
Group | ALT, U/L | AST, U/L | ALP, U/L | TBil, μmol/L | TG, mmol/L | TC, mmol/L |
Control | 21.5 ± 3.6 | 35.2 ± 5.1 | 24.8 ± 3.9 | 2.4 ± 0.5 | 1.4 ± 0.3 | 3.1 ± 0.4 |
HS (without correction) | 36.9 ± 5.4* | 49.8 ± 6.2* | 31.2 ± 4.7* | 3.3 ± 0.6* | 3.2 ± 0.5* | 5.0 ± 0.6* |
HS+SLCA-200 | 30.4 ± 4.6*# | 43.5 ± 5.7*# | 28.6 ± 4.3*# | 2.9 ± 0.5# | 2.5 ± 0.4*# | 4.1 ± 0.5*# |
HS+SLCA-400 | 25.7 ± 4.0# | 38.9 ± 5.2# | 26.1 ± 4.0# | 2.6 ± 0.5# | 1.9 ± 0.3# | 3.4 ± 0.4# |
TH (without correction) | 44.8 ± 6.1* | 68.4 ± 8.0* | 40.2 ± 5.9* | 5.6 ± 0.9* | 2.2 ± 0.4* | 4.0 ± 0.5* |
TH+SLCA-200 | 36.5 ± 5.2*# | 56.7 ± 7.1*# | 34.8 ± 5.2*# | 4.2 ± 0.7*# | 1.8 ± 0.3# | 3.5 ± 0.5# |
TH+SLCA-400 | 29.9 ± 4.5# | 46.2 ± 6.0# | 29.7 ± 4.5# | 3.2 ± 0.6# | 1.5 ± 0.3# | 3.1 ± 0.4# |
